HAMPTON ROADS, Va. - Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by myelin destruction and axonal damage of the brain, optic nerves and spinal cord. MS affects approximately 2.3 million people worldwide. Dr.Robert Shin, Professor of Neurology at Georgetown University in Washington, D.C. and the Director of the Georgetown Multiple Sclerosis and Neuroimmunology Center and patient, Kerry, who was diagnosed with relapsing MS in 2012, join us to talk about a new treatment option to help manage MS.
Go to www.kesimpta.com for more information.
